Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest ...

Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...

U-500 regular insulin ... Novo Nordisk in the United Kingdom [voluntarily withdrawn in 2008]) became commercially available in 1997. Its use, primarily in obese patients with type 2 diabetes ...

Novo Nordisk NVO ... for its once-weekly insulin called Awiqli in the United States. Awiqli is currently approved in the EU, ...

It occurs when the cells in your body don’t respond to insulin the way they should. This can lead to type 2 diabetes down the road. Experts suggest that more than 1 in 3 Americans have ...

Among the drugs selected in this round are Novo Nordisk’s blockbuster weight ... these drugs to treat conditions such as cancer, type 2 diabetes, and asthma, with these medications accounting ...

high deductibles and restrictive formularies can make insulin unaffordable. We know that as the healthcare system has changed a growing number of Americans with diabetes struggle to pay for their ...